Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan.
Hsieh MH, Yeh ML, Su TH,  et al
J Formos Med Assoc. 2017 Jul 7
Abstract

Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.
Holmes JA, Yu ML, Chung RT.
Expert Opin Drug Saf. 2017 May 4
Abstract

HCV/HBV coinfection: the dark side of DAAs treatment?
Madonia S, Orlando E, Madonia G, Cannizzaro M.
Liver Int. 2016 Dec 14.
Abstract

Ledipasvir and sofosbuvir for HCV-infection in patients coinfected with HBV.
Gane EJ, Hyland RH, An D, et al
Antivir Ther. 2016 Jul 1
Abstract

Inexplicable Outcome of Early Appearance of Hepatocellular Carcinoma in the Allograft After Deceased Donor Liver Transplantation: A Case Report.
Navarro Burgos JB, Lee KW, Shin YC, et al
Transplant Proc. 2015 Dec;47(10):3012-5.
Abstract

Hepatitis B Reactivation During Successful HCV Therapy.
Benítez L, de Mendoza C.
AIDS Rev. 2015 Jul-Sep;17(3):186.
Abstract

Does hepatitis B virus coinfection have any impact on treatment outcome in hepatitis C patients on hemodialysis?
Wahle RC, de Mello Perez R, Takemi Emori C, et al
Ann Hepatol. 2015 May-Jun 2015;
Abstract

The fatigue impact scale for daily use in patients with hepatitis B virus and hepatitis C virus chronic infections.
Miranda-Pettersen K, Morais-de-Jesus M, Daltro-Oliveira R,  et al
Ann Hepatol. 2015 May-jun 2015;14(3):310-316.
Abstract

Multiplex fluorescence quantitative polymerase chain reaction for simultaneous detection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus.
Tan B, Qin L, Chen C,
et alClin Lab. 2015;61(1-2):53-9.
Abstract

Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.
Zampino R, Pisaturo MA, Cirillo G, et al
Ann Hepatol. 2015 Jan-Feb 2015;14(1):75-82.
Abstract

HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study.
Zhang F, Zhu H, Wu Y, et al
Lancet Infect Dis. 2014 Oct 7.
Abstract

Hepatic Decompensation in HIV/HBV/HCV Patients Compared to HIV/HCV Patients and the Impact of Anti-HBV Nucleos(t)ide Therapy.
Lo Re V, Wang L, Devine S,  et al
Clin Infect Dis. 2014 Jun 18.
Abstract

Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E, Pisaturo M, Martini S,  et al
Expert Opin Pharmacother. 2014 Apr 29..
Abstract

FULL-TEXT ARTICLE
Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection.
Liu CJ, Chen PJ.
World J Gastroenterol. 2014 Mar 21;20(11):2955-2961
Paper

Risk of cardiovascular disease associated with HCV and HBV co-infection among antiretroviral-treated HIV-infected individuals.
Gillis J, Smieja M, Cescon A,  et al
Antivir Ther. 2014 Jan 16.
Abstract

Prevalence and predictors of hepatitis B virus co-infection in a united states cohort of hepatitis C virus-infected patients.
T|yson GL, Kramer JR, Duan Z,  et al
Hepatology. 2013 Mar 16.
Abstract

Outcomes of liver transplantation from hepatitis B core antibody-positive donors in viral cirrhosis patients: the prevailing negative effect of recipient hepatitis C virus infection.
Tandoi F, Romagnoli R, Martini S, et
Transplant Proc. 2012 Sep;44(7):1963-5.
Abstract

Outcomes of liver transplantation in simultaneously hepatitis B surface antigen and hepatitis C virus RNA positive recipients: the deleterious effect of donor hepatitis B core antibody positivity.
Tandoi F, Romagnoli R, Martini S,  et al
Transplant Proc. 2012 Sep;44(7):1960-
Abstract

Outcome of Liver Transplantation for Recipients With Hepatitis B and Hepatitis C Virus Coinfection: Analysis of the UNOS Data.
Waki K, Sugawara Y, Tamura S,
Transplantation. 2011 Oct 15;92(7):809-814.
Abstract